- Home
- VYNE vs BREA Comparison
VYNE vs BREA Comparison
Compare VYNE & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- BREA
- Stock Information
- Founded
- VYNE 2003
- BREA 2022
- Country
- VYNE United States
- BREA Ireland
- Employees
- VYNE N/A
- BREA N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- VYNE Health Care
- BREA Consumer Discretionary
- Exchange
- VYNE Nasdaq
- BREA Nasdaq
- Market Cap
- VYNE 16.0M
- BREA 13.6M
- IPO Year
- VYNE 2018
- BREA 2023
- Fundamental
- Price
- VYNE $1.45
- BREA $7.55
- Analyst Decision
- VYNE Strong Buy
- BREA
- Analyst Count
- VYNE 2
- BREA 0
- Target Price
- VYNE $6.25
- BREA N/A
- AVG Volume (30 Days)
- VYNE 1.3M
- BREA 18.1K
- Earning Date
- VYNE 08-13-2025
- BREA 01-01-0001
- Dividend Yield
- VYNE N/A
- BREA N/A
- EPS Growth
- VYNE N/A
- BREA N/A
- EPS
- VYNE N/A
- BREA N/A
- Revenue
- VYNE $605,000.00
- BREA $2,988,009.00
- Revenue This Year
- VYNE $42.51
- BREA N/A
- Revenue Next Year
- VYNE N/A
- BREA N/A
- P/E Ratio
- VYNE N/A
- BREA N/A
- Revenue Growth
- VYNE 43.03
- BREA 151.51
- 52 Week Low
- VYNE $0.85
- BREA $5.00
- 52 Week High
- VYNE $4.30
- BREA $19.50
- Technical
- Relative Strength Index (RSI)
- VYNE 56.76
- BREA 58.43
- Support Level
- VYNE $0.85
- BREA $5.90
- Resistance Level
- VYNE $1.96
- BREA $7.78
- Average True Range (ATR)
- VYNE 0.20
- BREA 0.68
- MACD
- VYNE 0.07
- BREA 0.07
- Stochastic Oscillator
- VYNE 51.80
- BREA 91.00
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.